Abstract | BACKGROUND: METHODS: Serum WFA(+)-M2BP values were retrospectively evaluated in 289 patients with NAFLD who had undergone liver biopsy. Histological findings were evaluated by three blinded, experienced liver-specific pathologists. RESULTS: For stages 0 (n = 35), 1 (n = 113), 2 (n = 49), 3 (n = 41), and 4 (n = 51) of liver fibrosis, the serum WFA(+)-M2BP cutoff indexes were 0.57, 0.70, 1.02, 1.57, and 2.96, respectively. Multivariate regression analysis showed that serum WFA(+)-M2BP values were associated with the stage of fibrosis (≥stage 2). The areas under the receiver operating characteristic curve (AUROC), sensitivity, and specificity of serum WFA(+)-M2BP were 0.876, 85.9, and 74.6%, respectively, for severe fibrosis (≥stage 3) and were 0.879, 74.6, and 87.0%, respectively, for cirrhosis. When compared with six non-invasive conventional markers, serum WFA(+)-M2BP had the greatest AUROC for diagnosing severe fibrosis and cirrhosis. CONCLUSIONS: Serum WFA(+)-M2BP values are useful for assessing the stage of liver fibrosis in patients with NAFLD.
|
Authors | Masanori Abe, Teruki Miyake, Atsushi Kuno, Yasuharu Imai, Yoshiyuki Sawai, Keisuke Hino, Yuichi Hara, Shuhei Hige, Michiie Sakamoto, Gotaro Yamada, Masayoshi Kage, Masaaki Korenaga, Yoichi Hiasa, Masashi Mizokami, Hisashi Narimatsu |
Journal | Journal of gastroenterology
(J Gastroenterol)
Vol. 50
Issue 7
Pg. 776-84
(Jul 2015)
ISSN: 1435-5922 [Electronic] Japan |
PMID | 25326152
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Neoplasm
- Membrane Glycoproteins
- Plant Lectins
- Receptors, N-Acetylglucosamine
- TAA90K protein, human
- wisteria lectin
|
Topics |
- Antigens, Neoplasm
(blood)
- Biopsy
- Cross-Sectional Studies
- Disease Progression
- Female
- Humans
- Liver
(pathology)
- Liver Cirrhosis
(blood, diagnosis, etiology)
- Male
- Membrane Glycoproteins
(blood)
- Middle Aged
- Non-alcoholic Fatty Liver Disease
(blood, complications, diagnosis)
- Plant Lectins
(blood)
- Receptors, N-Acetylglucosamine
(blood)
- Retrospective Studies
|